EdgarLookup

Galbraith Kenneth

Insider transactions at 2 companies

This page shows all SEC Form 4 filings attributed to Galbraith Kenneth. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

ZYME MGNX
Company Title Type Shares Price Value Date
ZYME Chair & CEO Option Exercise 100,000 Dec 22, 2025
ZYME Chair & CEO Option Exercise 47,666 Jan 6, 2025
ZYME Chair & CEO Sale 18,198 $10.65 $193,809 Jan 5, 2024
MGNX Sale 6,924 $27.11 $187,710 Sep 9, 2020
MGNX C 1,050,652 Oct 16, 2013